Operating Profit 更改
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
Chugai Pharma JPY 106.69B 5.93B 2023-09
Daiichi Sankyo JPY 51.03B 7B 2023-09
Enanta Pharmaceuticals USD -31030000 5.68M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Incyte USD 187.27M 27.44M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Novavax USD -125632000 181.09M 2023-09
PTC Therapeutics USD -131738000 13.57M 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



BioCryst Pharmaceuticals 营业利润 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.